Fosamax and Esophageal Cancer

A recent British study has linked bisphosphonates, including the popular drug Fosamax, to a doubled risk of developing esophageal cancer.  Fosamax and other bisphosphonate drugs are prescribed to prevent bone loss and osteoporosis.  The study found that patients who had taken bisphosphonates for over five years were nearly twice as likely to develop cancer of the esophagus than patients who had never taken bisphosphonates.  Patients who were prescribed any bisphosphonate, including Fosamax, for any length of time experienced a 30% increased risk of developing esophageal cancer over patients who were never prescribed the drug.

We Can Help

If you or a loved one has developed cancer of the esophagus while taking Fosamax or any other bisphosphonate drug, The Law Offices of Larry H. Parker can help.  We work with a nationally recognized team of pharmaceutical litigation law firms, and our team has a history of success, winning numerous difficult cases, including over 200 Vioxx, 150 Ortho Evra, and 50 fen-phen cases.

To schedule a confidential, no obligation consultation absolutely free, contact us by phone at (800) 333-0000 or by email using our case submission form.  If we don't get you any money, we won't charge you a dime.  The Law Offices of Larry H. Parker accepts product liability cases throughout the United States, with offices in Long Beach, Los Angeles, Riverside, Bakersfield, and Fresno, California, and Phoenix and Tucson, Arizona. 

Tough times call for tough lawyers.  We'll fight for you!

Fosamax® and Vioxx® are registered trademarks of Merck & Co., Inc.  Ortho Evra® is a registered trademark of Ortho-McNeil Pharmaceutical, Inc.